Journal rankings · indicator year 2018
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2018
Infectious Diseases journal rankings 2018
210 ranked journals · Subfield in Medicine
Infectious Diseases has 210 ranked journals in 2018. The median journal has an OJR of 0.87, below the world average of 1.00, unchanged on 2017; Q1 starts at OJR 1.43. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and PLoS Medicine.
Ranks and citation indicators: 2018. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2015–2017, the window the 2018 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery901
- Pulmonary and Respiratory Medicine349
- Public Health, Environmental and Occupational Health289
- Cardiology and Cardiovascular Medicine280
- Oncology224
- Infectious Diseases210
- Epidemiology193
- Endocrinology, Diabetes and Metabolism162
- Neurology161
- Physiology155
- Radiology, Nuclear Medicine and Imaging146
- Psychiatry and Mental health141
Show all 42 subfields
- Orthopedics and Sports Medicine115
- Pediatrics, Perinatology and Child Health101
- Ophthalmology95
- Dermatology89
- Hematology78
- Obstetrics and Gynecology73
- Rheumatology65
- Nephrology59
- Complementary and alternative medicine54
- Pharmacology51
- Reproductive Medicine50
- Emergency Medicine42
- Geriatrics and Gerontology34
- Rehabilitation34
- Otorhinolaryngology33
- Pathology and Forensic Medicine30
- Hepatology24
- Critical Care and Intensive Care Medicine23
- Immunology and Allergy21
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology15
- Gastroenterology7
- Internal Medicine4
- Transplantation3
- Family Practice2
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
210 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2017. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2015–2017, the window the 2018 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2015–2017 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2009 to 2018. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 15.99Q1 | 28.48 6.87 down from 2017 | 2,913 | 34% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 11.21Q1 | 19.82 4.81 down from 2017 | 114 | 95% | — | ||
3PLoS MedicineOAPublic Library of Science · United States | 6.05Q1 | 11.32 0.33 down from 2017 | 653 | 100% | $6,460 | ||
4MMWR Morbidity and Mortality Weekly ReportOACenters for Disease Control and Prevention · United States | 5.84Q1 | 11.31 1.61 down from 2017 | 837 | 99% | — | ||
5The Lancet Infectious DiseasesElsevier BV · Netherlands | 4.28Q1 | 10.39 0.04 down from 2017 | 1,101 | 51% | $7,280 | ||
6Annals of Internal MedicineAmerican College of Physicians · United States | 4.05Q1 | 7.40 0.59 down from 2017 | 1,297 | 11% | — | ||
7Virus EvolutionOAUniversity of Oxford · United Kingdom | 3.50Q1 | 5.56 3.60 down from 2017 | 108 | 100% | $3,304 | ||
8The Lancet Global HealthOAElsevier BV · Netherlands | 3.49Q1 | 6.32 0.14 up from 2017 | 727 | 100% | $6,680 | ||
9Clinical Infectious DiseasesOxford University Press · United States | 3.04Q1 | 7.19 0.92 down from 2017 | 2,320 | 77% | $4,763 | ||
10EurosurveillanceOAEuropean Centre for Disease Prevention and Control · Sweden | 3.03Q1 | 7.92 0.05 up from 2017 | 642 | 100% | — | ||
11PLoS PathogensOAPublic Library of Science · United States | 2.98Q1 | 7.31 0.08 down from 2017 | 1,992 | 100% | $3,043 | ||
12npj VaccinesOANature Portfolio · United Kingdom | 2.86Q1 | 6.00 2.14 up from 2017 | 50 | 100% | $3,890 | ||
13The Lancet HIVElsevier BV · Netherlands | 2.59Q1 | 6.62 1.39 up from 2017 | 363 | 41% | $7,280 | ||
14Microbiology SpectrumOAAmerican Society for Microbiology · United States | 2.57Q1 | 5.46 0.85 up from 2017 | 481 | 100% | $2,500 | ||
15Therapeutic Advances in Infectious DiseaseOASAGE Publishing · United Kingdom | 2.50Q1 | 3.31 5.13 down from 2017 | 33 | 100% | $2,800 | ||
16Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.45Q1 | 5.04 0.81 down from 2017 | 1,634 | 100% | — | ||
17VaccinesOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.45Q1 | 5.99 0.55 down from 2017 | 149 | 100% | $3,258 | ||
18Emerging Microbes & InfectionsOATaylor & Francis · United Kingdom | 2.33Q1 | 5.44 0.33 up from 2017 | 245 | 100% | $2,643 | ||
19JMIR Public Health and SurveillanceOAJMIR Publications · Canada | 2.29Q1 | 4.20 0.55 down from 2017 | 171 | 100% | $2,800 | ||
20Current HIV/AIDS ReportsSpringer Science+Business Media · United States | 2.27Q1 | 5.13 0.85 down from 2017 | 124 | 70% | $4,190 | ||
21Clinical Microbiology and InfectionElsevier BV · United Kingdom | 2.18Q1 | 5.11 0.20 up from 2017 | 991 | 99% | $3,780 | ||
22mSphereOAAmerican Society for Microbiology · United States | 2.14Q1 | 5.08 0.30 up from 2017 | 356 | 100% | $3,500 | ||
23Journal of the International AIDS SocietyOAInternational AIDS Society · United States | 2.11Q1 | 5.30 0.99 up from 2017 | 497 | 100% | $2,600 | ||
24The Journal of Infectious DiseasesOxford University Press · United States | 2.10Q1 | 4.76 0.20 down from 2017 | 1,785 | 87% | $4,763 | ||
25PathogensOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.04Q1 | 4.06 0.47 down from 2017 | 187 | 100% | $2,654 | ||
26Antiviral ResearchElsevier BV · Netherlands | 2.03Q1 | 4.47 0.62 down from 2017 | 653 | 48% | $4,160 | ||
27Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.99Q1 | 5.12 0.75 up from 2017 | 1,529 | 96% | — | ||
28Current Opinion in HIV and AIDSLippincott Williams & Wilkins · United Kingdom | 1.99Q1 | 4.12 0.67 down from 2017 | 253 | 30% | — | ||
29VirusesOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.98Q1 | 4.60 0.02 down from 2017 | 1,091 | 100% | $3,137 | ||
30Infectious Diseases and TherapyOAAdis, Springer Healthcare · United Kingdom | 1.94Q1 | 5.10 1.20 up from 2017 | 120 | 100% | $7,400 | ||
31Infection and Drug ResistanceOADove Medical Press · New Zealand | 1.89Q1 | 3.78 1.29 down from 2017 | 133 | 100% | $2,836 | ||
32Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.74Q1 | 4.86 0.08 up from 2017 | 1,622 | 73% | $3,784 | ||
33Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 1.74Q1 | 5.02 0.48 up from 2017 | 2,991 | 95% | — | ||
34JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 1.69Q1 | 3.98 0.16 up from 2017 | 1,117 | 58% | — | ||
35VirulenceOATaylor & Francis · United States | 1.67Q1 | 4.14 0.61 up from 2017 | 331 | 100% | $2,557 | ||
36AIDS Patient Care and STDsMary Ann Liebert, Inc. · United States | 1.64Q1 | 4.05 0.22 down from 2017 | 213 | 70% | — | ||
37HIV/AIDS - Research and Palliative CareOADove Medical Press · New Zealand | 1.62Q1 | 2.59 0.29 down from 2017 | 70 | 100% | $2,320 | ||
38AIDSLippincott Williams & Wilkins · United Kingdom | 1.59Q1 | 3.94 0.08 up from 2017 | 1,164 | 64% | — | ||
39Journal of InfectionOAElsevier BV · United Kingdom | 1.57Q1 | 3.80 0.06 up from 2017 | 598 | 36% | $4,030 | ||
40International Journal of Medical MicrobiologyOAElsevier BV · Germany | 1.55Q1 | 3.74 0.49 up from 2017 | 260 | 27% | $3,410 | ||
41Antimicrobial Resistance and Infection ControlOABioMed Central · United Kingdom | 1.55Q1 | 4.45 0.89 up from 2017 | 281 | 100% | $3,290 | ||
42BMC Infectious DiseasesOABioMed Central · United Kingdom | 1.52Q1 | 3.42 0.12 down from 2017 | 2,123 | 100% | $3,090 | ||
43Current Infectious Disease ReportsSpringer Science+Business Media · United States | 1.52Q1 | 3.98 0.68 up from 2017 | 148 | 24% | $4,390 | ||
44Reviews in Medical VirologyWiley · United Kingdom | 1.50Q1 | 2.41 1.09 down from 2017 | 137 | 39% | $4,880 | ||
45AnaerobeElsevier BV · United Kingdom | 1.50Q1 | 3.50 0.34 up from 2017 | 421 | 26% | $3,350 | ||
46Clinics in Laboratory MedicineElsevier BV · United States | 1.49Q1 | 2.78 0.28 up from 2017 | 165 | 17% | $3,000 | ||
47AIDS Education and PreventionGuilford Press · United States | 1.48Q1 | 2.41 0.56 down from 2017 | 122 | 50% | — | ||
48World Journal of Experimental MedicineOAUnited States | 1.48Q1 | 4.00 0.71 down from 2017 | 45 | 100% | — | ||
49Brazilian Journal of MicrobiologySpringer Nature · Brazil | 1.47Q1 | 3.36 0.73 up from 2017 | 491 | 100% | $3,190 | ||
50British Journal of Clinical PharmacologyWiley · United Kingdom | 1.47Q1 | 3.60 0.18 down from 2017 | 837 | 97% | $4,780 |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery901
- Pulmonary and Respiratory Medicine349
- Public Health, Environmental and Occupational Health289
- Cardiology and Cardiovascular Medicine280
- Oncology224
- Infectious Diseases210
- Epidemiology193
- Endocrinology, Diabetes and Metabolism162
- Neurology161
- Physiology155
- Radiology, Nuclear Medicine and Imaging146
- Psychiatry and Mental health141
- Orthopedics and Sports Medicine115
- Pediatrics, Perinatology and Child Health101
- Ophthalmology95
- Dermatology89
- Hematology78
- Obstetrics and Gynecology73
- Rheumatology65
- Nephrology59
- Complementary and alternative medicine54
- Pharmacology51
- Reproductive Medicine50
- Emergency Medicine42
- Geriatrics and Gerontology34
- Rehabilitation34
- Otorhinolaryngology33
- Pathology and Forensic Medicine30
- Hepatology24
- Critical Care and Intensive Care Medicine23
- Immunology and Allergy21
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology15
- Gastroenterology7
- Internal Medicine4
- Transplantation3
- Family Practice2
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2018. Corpus-wide, 81.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
51 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2015–2017, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2018. Publication window: 2015–2017. How these summaries are calculated
- Ranked journals
- 210
- Window papers (baseline)
- 70,742 +12.8% from indicator year 2015
- Median OJR
- 0.8696 -0.5% from indicator year 2015
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2015–2017 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.